PAT-048

N/A

Report date: 2022/06/29 14:24:48
NME

Base Information

Drug NamePAT-048
Drug Alias NamePAT-048
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors
TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2
Therapy Area/IndicationsFibrosisPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmakea Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmakea Inc
Inactive CompaniesN/A
Active IndicationsFibrosisPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A